Combination of ECMO and cytokine adsorption therapy for severe sepsis with cardiogenic shock and ARDS due to Panton–Valentine leukocidin—positive Staphylococcus aureus pneumonia and H1N1

Journal of Artificial Organs

Volumn 19, Issue 4, 2016, Pages 399-402

  Lees, Nj ^a   Rosenberg, Ajp ^a   Hurtado Doce, Ai ^a   Jones, J ^a   Marczin, N ^a,b,c   Zeriouh, M ^a   Weymann, A ^a   Sabashnikov, A ^a   Simon, Ar ^a   Popov, Af ^a  

^a HAREFIELD HOSPITAL   (United Kingdom)

^b IMPERIAL COLLEGE LONDON   (United Kingdom)

^c SEMMELWEIS UNIVERSITY   (Hungary)

Author keywords

Adsorption therapy; Cytokines; Extracorporeal membrane oxygenation (ECMO); H1N1; Sepsis

Indexed keywords

CLINDAMYCIN; DOBUTAMINE; IMMUNOGLOBULIN G; LEVOSIMENDAN; NORADRENALIN; PANTON VALENTINE LEUKOCIDIN; VASOPRESSIN; BACTERIAL TOXIN; CYTOKINE; EXOTOXIN; LEUKOCIDIN; PANTON-VALENTINE LEUKOCIDIN;

ABDOMINAL PAIN; ACUTE RESPIRATORY FAILURE; ADULT; ADULT RESPIRATORY DISTRESS SYNDROME; ARTICLE; ARTIFICIAL VENTILATION; CARDIOGENIC SHOCK; CASE REPORT; CONSERVATIVE TREATMENT; CYTOKINE ADSORPTION THERAPY; DELIRIUM; DISEASE SEVERITY; DYSPNEA; EXTRACORPOREAL OXYGENATION; FEMALE; FEVER; FORCED EXPIRATORY VOLUME; FORCED VITAL CAPACITY; HEART LEFT VENTRICLE EJECTION FRACTION; HEART LEFT VENTRICLE FAILURE; HUMAN; HYPOTENSION; HYPOXEMIA; INFLUENZA A (H1N1); METABOLIC ACIDOSIS; NEUTROPENIA; OUTCOME ASSESSMENT; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; SEPSIS; STAPHYLOCOCCAL PNEUMONIA; TACHYCARDIA; TACHYPNEA; TRANSTHORACIC ECHOCARDIOGRAPHY; ADSORPTION; COMPLICATION; HEMOPERFUSION; INFLUENZA; INFLUENZA A VIRUS (H1N1); ISOLATION AND PURIFICATION; METABOLISM; RESPIRATORY DISTRESS SYNDROME, ADULT; RESPIRATORY INSUFFICIENCY; SHOCK, CARDIOGENIC; STAPHYLOCOCCUS AUREUS; VIROLOGY;

ADSORPTION; ADULT; BACTERIAL TOXINS; CYTOKINES; EXOTOXINS; EXTRACORPOREAL MEMBRANE OXYGENATION; FEMALE; HEMOPERFUSION; HUMANS; INFLUENZA A VIRUS, H1N1 SUBTYPE; INFLUENZA, HUMAN; LEUKOCIDINS; PNEUMONIA, STAPHYLOCOCCAL; RESPIRATORY DISTRESS SYNDROME, ADULT; RESPIRATORY INSUFFICIENCY; SEPSIS; SHOCK, CARDIOGENIC; STAPHYLOCOCCUS AUREUS;

EID: 84978758116     PISSN: 14347229     EISSN: 16190904     Source Type: Journal    
DOI: 10.1007/s10047-016-0915-8     Document Type: Article

References (17)

1. Gillet Y, Issartel B, Vanhems P, et al. Association between Staphylococcus aureus strains carrying gene for Panton–Valentine leukocidin and highly lethal necrotising pneumonia in young immunocompetent patients. Lancet. 2002;359:753–9.
2. Gauduchon V, Cozon G, Vandenesch F, et al. Neutralization of Staphylococcus aureus Panton–Valentine leukocidin by intravenous immunoglobulin in vitro. J Infect Dis. 2004;189:346–53.
3. Rouzic N, Janvier F, Libert N, et al. Prompt and successful toxin-targeting treatment of three patients with necrotizing pneumonia due to Staphylococcus aureus strains carrying the Panton–Valentine leukocidin genes. J Clin Microbiol. 2010;48:1952–5.
4. Morgan MS. Diagnosis and treatment of Panton–Valentine leukocidin (PVL)-associated staphylococcal pneumonia. Int J Antimicrob Agents. 2007;30:289–96.
5. Salliot C, Zeller V, Puechal X, et al. Panton–Valentine leukocidin-producing Staphylococcus aureus infections: report of 4 French cases. Scand J Infect Dis. 2006;38:192–5.
6. Noah MA, Dawrant M, Faulkner GM, et al. Panton–Valentine leukocidin expressing Staphylococcus aureus pneumonia managed with extracorporeal membrane oxygenation: experience and outcome. Crit Care Med. 2010;38:2250–3.
7. Fujisaki N, Takahashi A, Arima T, et al. Successful treatment of Panton–Valentine leukocidin-expressing Staphylococcus aureus-associated pneumonia co-infected with influenza using extracorporeal membrane oxygenation. In Vivo. 2014;28:961–5.
8. Maclaren G, Butt W. Extracorporeal membrane oxygenation and sepsis. Critical care and resuscitation J Australas Acad Cri Care Med. 2007;9:76–80.
9. Brechot N, Luyt CE, Schmidt M, et al. Venoarterial extracorporeal membrane oxygenation support for refractory cardiovascular dysfunction during severe bacterial septic shock. Crit Care Med. 2013;41:1616–26.
10. Gabel E, Gudzenko V, Cruz D, et al. Successful use of extracorporeal membrane oxygenation in an adult patient with toxic shock-induced heart failure. J Intensive Care Med. 2015;30:115–8.
11. Nakada TA, Oda S, Matsuda K, et al. Continuous hemodiafiltration with PMMA hemofilter in the treatment of patients with septic shock. Mol Med. 2008;14:257–63.
12. Song M, Winchester J, Albright RL, et al. Cytokine removal with a novel adsorbent polymer. Blood Purif. 2004;22:428–34.
13. Morris C, Gray L, Giovannelli M. Early report: the use of Cytosorb haemoabsorption column as an adjunct in managing severe sepsis: initial experiences, review and recommendations. J Intensive Care Soc. 2015;16:257–64.
14. Hetz H, Berger R, Recknagel P, et al. Septic shock secondary to beta-hemolytic streptococcus-induced necrotizing fasciitis treated with a novel cytokine adsorption therapy. Int J Artif Organs. 2014;37:422–6.
15. Basu R, Pathak S, Goyal J, et al. Use of a novel hemadsorption device for cytokine removal as adjuvant therapy in a patient with septic shock with multi-organ dysfunction: a case study. Indian J Crit Care Med. 2014;18:822–4.
16. Bruenger F, Kizner L, Weile J, et al. First successful combination of ECMO with cytokine removal therapy in cardiogenic septic shock: a case report. Int J Artif Organs. 2015;38:113–6.
17. Bracht H, Schneider EM, Weiss M, Hohmann H, Georgieff M, Barth E. Pattern of cytokine removal using an adsorption column CytoSorb during severe Candida albicans induced septic shock. Infection. 2013;41:S1–90.